News & Analysis on Clinical Trial Services & Contract Research And Development
INC Research Japan
By Dan Stanton
- Last updated on
There are three new appointments at INC Research in Japan:
Hiromi Wakita will serve as General Manager and Clinical Director and will lead the Company’s operations in Japan, whilst Hiroshi Uoji joins as Regulatory and Safety Director and Shinichi Sato joins as Project Director, CNS Clinical Development.
“As the world’s second largest pharmaceutical market, Japan offers huge potential in terms of advancing new medicines globally,” said Executive VP for Asia Garth Tierney.
“Having an experienced leadership team in place to better assist customers in gaining access to the world’s No. 2 ranked product market, while helping them navigate some of the cultural and regulatory differences in conducting research here, is key.”